Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BPTF | Q12830 | 1/20 | 0.38 |
| ▸ | SCN9A | Q15858 | 11/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.36 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.35 |
| ▸ | HPGD | P15428 | 1/20 | 0.35 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.34 |
| ▸ | SCN7A | Q01118 | 1/20 | 0.34 |
| ▸ | SCN5A | Q14524 | 1/20 | 0.34 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.33 |
| ▸ | SIGMAR1 | Q99720 | 3/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21136043 | 0.76 | ALDH1A1 (0.35) | SCN9AALDH1A1EPHX1SCN5A | |
| SCHEMBL21136976 | 0.76 | EPHX1 (0.33) | SCN9AEPHX1SCN5A | |
| SCHEMBL21136970 | 0.72 | SMN1; SMN2 (0.34) | SCN9AALDH1A1EPHX1 | |
| SCHEMBL3790410 | 0.72 | ALDH1A1 (0.36) | ALDH1A1EPHX1 | |
| SCHEMBL3785565 | 0.71 | ALDH1A1 (0.35) | BPTFALDH1A1EPHX1 | |
| SCHEMBL21136013 | 0.70 | EPHX1 (0.32) | BPTFALDH1A1L3MBTL1EPHX1 | |
| SCHEMBL23640669 | 0.68 | HSD11B1 (0.32) | ALDH1A1HSD11B1 | |
| SCHEMBL21135952 | 0.67 | ALDH1A1 (0.35) | ALDH1A1L3MBTL1HSD11B1 | |
| SCHEMBL21135971 | 0.67 | CNR2 (0.32) | BPTFALDH1A1L3MBTL1EPHX1 | |
| SCHEMBL9609347 | 0.66 | CA1 (0.41) | ALDH1A1L3MBTL1KDM4EHPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20190196326-A1 | ACTINIC RAY-SENSITIVE OR RADIATION-SENSITIVE RESIN COMPOSITION, RESIST FILM, PATTERN FORMING METHOD, AND METHOD OF MANUFACTURING ELECTRONIC DEVICE | FUJIFILM CORPORATION (JP) | 2019-06-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190196326-A1 | ACTINIC RAY-SENSITIVE OR RADIATION-SENSITIVE RESIN COMPOSITION, RESIST FILM, PATTERN FORMING METHOD, AND METHOD OF MANUFACTURING ELECTRONIC DEVICE | RER1, ACTR5, RAD51 | BPTF 1176/4885SCN9A 2257/4885ALDH1A1 1556/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.